Molecular variants of soluble guanylyl cyclase affecting cardiovascular risk

Circulation Journal : Official Journal of the Japanese Circulation Society
Jana WobstHeribert Schunkert

Abstract

Soluble guanylyl cyclase (sGC) is the physiological receptor for nitric oxide (NO) and NO-releasing drugs, and is a key enzyme in several cardiovascular signaling pathways. Its activation induces the synthesis of the second messenger cGMP. cGMP regulates the activity of various downstream proteins, including cGMP-dependent protein kinase G, cGMP-dependent phosphodiesterases and cyclic nucleotide gated ion channels leading to vascular relaxation, inhibition of platelet aggregation, and modified neurotransmission. Diminished sGC function contributes to a number of disorders, including cardiovascular diseases. Knowledge of its regulation is a prerequisite for understanding the pathophysiology of deficient sGC signaling. In this review we consolidate the available information on sGC signaling, including the molecular biology and genetics of sGC transcription, translation and function, including the effect of rare variants, and present possible new targets for the development of personalized medicine in vascular diseases.

References

Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S LamasT Michel
Nov 30, 1988·Biochemical and Biophysical Research Communications·J B HibbsE M Rachlin
Jun 30, 1988·Biochemical and Biophysical Research Communications·R M PalmerS Moncada
Nov 1, 1993·Cardiovascular Research·P C Ursell, M Mayes
Jun 1, 1995·Annals of Medicine·R Busse, I Fleming
Jan 1, 1994·Advances in Pharmacology·T D WarnerF Murad
Jan 31, 1998·Biochemistry·Y Zhao, M A Marletta
Sep 22, 1998·The Biochemical Journal·M RusswurmD Koesling
Oct 8, 1999·Biochemical and Biophysical Research Communications·J BudworthK Powell
Apr 25, 2000·Biochemical and Biophysical Research Communications·S Behrends, K Vehse
Dec 23, 2003·The International Journal of Biochemistry & Cell Biology·Hideaki Okamoto
Aug 25, 2004·Proceedings of the National Academy of Sciences of the United States of America·Patricia PellicenaJohn Kuriyan
Sep 7, 2004·The Journal of Biological Chemistry·Khalid A HanafyFerid Murad
Nov 3, 2004·Pharmacology & Therapeutics·Pius S PadayattiFocco van den Akker
Mar 8, 2005·The Journal of Biological Chemistry·Corina WagnerDoris Koesling
Sep 14, 2006·Pharmacological Reviews·Andrew T Bender, Joseph A Beavo
Mar 7, 2007·British Journal of Pharmacology·C GerassimouA Papapetropoulos
May 1, 2007·Cardiovascular Research·David A KassHunter C Champion
Jul 6, 2007·Cardiovascular Research·Sofie NimmegeersJohan Van de Voorde
Jul 20, 2007·The New England Journal of Medicine·Nilesh J SamaniUNKNOWN WTCCC and the Cardiogenics Consortium
Jul 24, 2007·Cellular Signalling·Michelle Bellingham, Thomas J Evans
Apr 3, 2008·The Journal of Biological Chemistry·Iraida G SharinaFerid Murad
Jun 21, 2008·The FEBS Journal·Roberto I Vazquez-PadronAbdelouahab Aitouche
Oct 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Annika RauchClemens Steegborn
Dec 18, 2008·Handbook of Experimental Pharmacology·Sharron H FrancisErwin Bischoff
Sep 4, 2009·Archives of Pharmacal Research·Claudio Napoli, Louis J Ignarro
Feb 13, 2010·Journal of Thrombosis and Haemostasis : JTH·O DangelA Friebe
Sep 13, 2011·Nature·UNKNOWN International Consortium for Blood Pressure Genome-Wide Association StudiesToby Johnson
Mar 13, 2012·Annual Review of Biochemistry·Emily R Derbyshire, Michael A Marletta

❮ Previous
Next ❯

Citations

Oct 12, 2018·The Journal of Physiology·E N Bardsley, D J Paterson
Oct 14, 2017·The American Journal of Cardiology·Kirsten LeineweberDan Paulson
Aug 9, 2021·European Journal of Medicinal Chemistry·Kevin M GaylerEmil Martin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Related Papers

Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie
F Murad
Arteriosclerosis, Thrombosis, and Vascular Biology
Zongmin ZhouAndreas Papapetropoulos
Annual Review of Biochemistry
Emily R Derbyshire, M A Marletta
© 2022 Meta ULC. All rights reserved